Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Park Ha Biological Technology Co., Ltd. ( (PHH) ) has provided an update.
On September 2, 2025, Park Ha Biological Technology Co., Ltd. received notifications from Nasdaq regarding non-compliance with two listing requirements: a minimum closing bid price of $1 per share and a market value of listed securities of $35 million. The company has until March 2, 2026, to address these deficiencies to avoid potential delisting. Park Ha intends to take necessary actions to regain compliance, though there is no assurance of success.
More about Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd. operates in the biotechnology industry, focusing on innovative life science solutions. The company is based in Wuxi, Jiangsu Province, China, and is involved in developing products and services that cater to the life sciences sector.
Average Trading Volume: 1,707,676
Technical Sentiment Signal: Strong Sell
Find detailed analytics on PHH stock on TipRanks’ Stock Analysis page.